<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.2: Diabetic Neuropathy: Protecting the Nervous System</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/NAVY theme for Medical/Neurology */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9fafb;
            border-radius: 12px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 16px;
            color: #1e3a8a;
        }

        .ref-list {
            list-style: none;
            padding: 0;
            margin: 0;
            font-size: 13px;
            color: #666;
            line-height: 1.6;
        }

        .ref-list li {
            margin-bottom: 10px;
            padding-left: 15px;
            position: relative;
        }

        .ref-list li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #3b82f6;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Pathophysiology & Complications</p>
            <h1 class="lesson-title">Lesson 8.2: Diabetic Neuropathy: Protecting the Nervous System</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 6</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Polyol Pathway Mechanism</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Peripheral Neuropathy (DPN)</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Autonomic Neuropathy (DAN)</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The STABLE Methodâ„¢ Approach</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Clinical Screening Tools</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Integrative Neuroprotection</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the biochemical mechanisms of nerve damage, including the polyol pathway and oxidative stress.</li>
                <li>Differentiate between the clinical presentations of peripheral, autonomic, proximal, and focal neuropathies.</li>
                <li>Analyze the impact of glycemic variability on nerve fiber density using the STABLE Methodâ„¢ principles.</li>
                <li>Identify the specific signs of Cardiac Autonomic Neuropathy (CAN) and Gastroparesis.</li>
                <li>Develop a comprehensive screening and neuroprotective strategy for coaching clients.</li>
            </ul>
        </div>

        <h2 id="section1">The Pathophysiology of Nerve Damage</h2>
        <p>Diabetic Neuropathy (DN) is not a single condition but a group of nerve disorders caused by chronic hyperglycemia. While Lesson 1 focused on <span class="highlight">Advanced Glycation End-products (AGEs)</span>, DN involves a specific biochemical cascade known as the <span class="highlight">Polyol Pathway</span>. When intracellular glucose levels rise in nerve cellsâ€”which do not require insulin for glucose uptakeâ€”the enzyme aldose reductase converts excess glucose into <strong>sorbitol</strong>.</p>

        <p>Sorbitol is a sugar alcohol that does not easily cross cell membranes. Its accumulation creates a powerful osmotic gradient, drawing water into the nerve cell and causing swelling. Furthermore, the conversion of sorbitol to fructose consumes NADPH, a critical cofactor for regenerating <span class="highlight">Glutathione</span>. This depletion leaves the nerve vulnerable to massive oxidative stress. A 2021 study published in <i>Antioxidants</i> demonstrated that this "oxidative-nitrosative stress" is the primary driver of nerve fiber apoptosis (cell death).</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Diabetics with Neuropathy</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Risk of Foot Ulcers</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Mortality if CAN present</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">Reduction via Tight Control</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Distal Symmetric Polyneuropathy (DPN)</h2>
        <p>This is the most common form of neuropathy, typically presenting in a <span class="highlight">"stocking-glove" distribution</span>. Because longer axons are more susceptible to metabolic damage, symptoms usually begin in the toes and feet before progressing to the hands. DPN affects three distinct types of nerve fibers:</p>

        <ul class="content-list">
            <li><strong>Small Sensory Fibers:</strong> Damage results in "positive" symptoms like burning, tingling (paresthesia), and sharp electric-shock pains.</li>
            <li><strong>Large Sensory Fibers:</strong> Damage results in "negative" symptoms like numbness, loss of protective sensation (LOPS), and impaired proprioception (balance).</li>
            <li><strong>Motor Fibers:</strong> Damage leads to muscle weakness, foot deformities (e.g., hammer toes), and changes in gait.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Peripheral Sensory Loss</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Peripheral Neuropathy Management</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">R</div>
                    <div class="patient-info">
                        <h4>Robert, 62</h4>
                        <p>Type 2 Diabetes (14 years) | A1c: 8.2% | Sedentary</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Robert complained of "walking on cotton wool" and intense burning sensations in his feet at night. He had recently stepped on a small tack and didn't realize it until he saw blood on his sock.</p>
                <p><strong>Intervention:</strong> Applied the <strong>STABLE Methodâ„¢</strong>. Focused on <i>Stabilization (S)</i> by reducing postprandial spikes from 220 mg/dL to <160 mg/dL. Introduced 600mg of Alpha-Lipoic Acid (ALA) daily and daily foot inspections.</p>
                <p><strong>Outcome:</strong> After 4 months, Robertâ€™s "burning" score dropped from 8/10 to 3/10. His A1c improved to 6.9%, and he regained partial sensation in his mid-foot.</p>
            </div>
        </div>

        <h2 id="section3">Diabetic Autonomic Neuropathy (DAN)</h2>
        <p>DAN is perhaps the most underdiagnosed and dangerous complication. It affects the involuntary nervous system that controls the heart, digestive tract, and bladder. Of particular concern is <span class="highlight">Cardiac Autonomic Neuropathy (CAN)</span>, which presents as a high resting heart rate (>100 bpm) and orthostatic hypotension (dizziness when standing). A meta-analysis of 12 studies (n=2,900) found that CAN is associated with a 3.4-fold increased risk of silent myocardial infarction (painless heart attack).</p>

        <p>Another common manifestation is <strong>Gastroparesis</strong>. This is the delayed emptying of the stomach in the absence of mechanical obstruction. It creates a "vicious cycle" for blood sugar management: insulin is injected for a meal, but the food sits in the stomach for hours, leading to early hypoglycemia followed by severe delayed hyperglycemia.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>System Affected</th>
                        <th>Symptoms</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Cardiovascular</strong></td>
                        <td>Resting tachycardia, exercise intolerance</td>
                        <td>High risk of sudden cardiac death</td>
                    </tr>
                    <tr>
                        <td><strong>Gastrointestinal</strong></td>
                        <td>Bloating, early satiety, nausea</td>
                        <td>Erratic blood sugar (Glucose-Insulin mismatch)</td>
                    </tr>
                    <tr>
                        <td><strong>Genitourinary</strong></td>
                        <td>Neurogenic bladder, erectile dysfunction</td>
                        <td>Frequent UTIs, decreased quality of life</td>
                    </tr>
                    <tr>
                        <td><strong>Sudomotor</strong></td>
                        <td>Anhidrosis (no sweat) in feet</td>
                        <td>Dry, cracked skin leading to infections</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">The STABLE Methodâ„¢: Neuroprotective Application</h2>
        <p>In the <strong>STABLE Methodâ„¢</strong>, we prioritize the <span class="highlight">Stabilization of Glycemic Variability (S)</span>. Research indicates that "glucose flutters" (frequent spikes and crashes) are more damaging to the delicate Schwann cells (which insulate nerves) than sustained, moderately high blood sugar. This is due to the repeated activation of the protein kinase C (PKC) pathway.</p>

        <p>By using <strong>Tactical Tracking (T)</strong> through CGM data, coaches can identify the "Neuropathy Threshold"â€”the glucose level at which a client begins to feel increased tingling. Often, this occurs when glucose exceeds 180 mg/dL. Identifying and "flattening" these spikes through <strong>Evolutionary-Based Nutrition (E)</strong>â€”specifically prioritizing fiber and protein before carbohydratesâ€”can halt the progression of nerve damage.</p>

        <h2 id="section5">Clinical Screening Tools for Coaches</h2>
        <p>While coaches do not provide medical diagnoses, they must be proficient in recognizing the signs of DPN to facilitate medical referrals. The Gold Standard for screening is the <strong>10-gram Semmes-Weinstein Monofilament Test</strong>. If a client cannot feel the pressure of the filament at 4 out of 10 specific points on the foot, they are at high risk for ulceration.</p>

        <p>Other vital assessments include:</p>
        <ul class="content-list">
            <li><strong>128-Hz Tuning Fork:</strong> Assessing vibration perception at the great toe. Loss of vibration sense is often the earliest sign of large-fiber damage.</li>
            <li><strong>Ankle Brachial Index (ABI):</strong> Checking for concurrent Peripheral Artery Disease (PAD), which often mimics neuropathy symptoms.</li>
            <li><strong>Heart Rate Variability (HRV):</strong> Using wearable technology to track the "R-R interval." A low HRV is a strong indicator of autonomic dysfunction.</li>
        </ul>

        <h2 id="section6">Integrative Management and Regeneration</h2>
        <p>The traditional medical approach focuses on "pain masking" (e.g., Gabapentin). As a Diabetes Coach, your focus is on <span class="highlight">metabolic neuroprotection</span>. Beyond blood sugar control, several targeted interventions show promise in clinical literature:</p>

        <ul class="content-list">
            <li><strong>Alpha-Lipoic Acid (ALA):</strong> A potent antioxidant that improves endoneurial blood flow. The SYDNEY 2 trial showed that 600mg daily significantly reduced pain and numbness within 5 weeks.</li>
            <li><strong>Benfotiamine:</strong> A lipid-soluble form of Vitamin B1 that blocks the polyol pathway and reduces AGE formation.</li>
            <li><strong>Acetyl-L-Carnitine:</strong> Shown in meta-analyses to stimulate nerve growth factor (NGF) and promote nerve fiber regeneration.</li>
            <li><strong>Active Sensitization (A):</strong> Resistance training has been shown to increase intraepidermal nerve fiber density (IENFD), essentially "re-growing" the endings of small nerves.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of neuropathic mechanisms</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which enzyme is responsible for converting excess glucose into sorbitol in the nerve cell, leading to osmotic swelling?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">The enzyme is <strong>Aldose Reductase</strong>. This is the first step in the Polyol Pathway, which is a major contributor to diabetic nerve damage.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">Why does the STABLE Methodâ„¢ emphasize 'Stabilization' over just lowering A1c for neuropathy clients?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Glycemic variability (spikes and crashes) causes more oxidative stress and Schwann cell damage than stable high glucose. Rapid fluctuations trigger the PKC pathway and inflammatory cytokines that accelerate nerve fiber death.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Diabetic Neuropathy affects 50% of patients and is the leading cause of non-traumatic amputations.</li>
                <li>The Polyol Pathway causes intracellular sorbitol accumulation, leading to osmotic stress and glutathione depletion.</li>
                <li>Autonomic neuropathy (DAN) can cause silent heart attacks and gastroparesis, making glucose management significantly more complex.</li>
                <li>Early detection using the 10g monofilament and vibration testing is essential for preventing foot ulcers.</li>
                <li>Neuroprotective strategies must include glycemic stabilization, antioxidant support (ALA), and resistance training.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="ref-list">
                <li>Pop-Busui et al. (2017). "Diabetic Neuropathy: A Position Statement by the American Diabetes Association." Diabetes Care.</li>
                <li>Feldman et al. (2019). "Diabetic neuropathy." Nature Reviews Disease Primers.</li>
                <li>Ziegler et al. (2021). "Current concepts in the management of diabetic neuropathy." Journal of Diabetes Investigation.</li>
                <li>Papanas et al. (2022). "Pathogenesis of Diabetic Neuropathy: The Role of Oxidative Stress." Antioxidants.</li>
                <li>Selvarajah et al. (2019). "Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening." The Lancet Diabetes & Endocrinology.</li>
                <li>Tesfaye et al. (2010). "Diabetic neuropathies: update on definitions and diagnostic criteria." Diabetes Care.</li>
                <li>Sun et al. (2020). "Effect of Alpha-Lipoic Acid on Diabetic Peripheral Neuropathy: A Meta-analysis." Journal of International Medical Research.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Specialized Certification in Metabolic Health.</p>
        </footer>
    </div>
</body>

</html>